Save time and money with
Med Tech Market
Research
MedTech Business intelligence
supplied through Trade Tracker, Research and Markets and GlobalData
Latest reports
Rheumatoid
Arthritis Therapeutics — Pipeline Assessment and Market Forecasts to
2018
Rheumatoid Arthritis Therapeutics Market is
Forecast to Show Moderate Growth Until 2018. GlobalData’s analysis
suggests that the global rheumatoid arthritis therapeutics market was
worth $10.3 billion in 2010 and forecast to grow at a CAGR of 3.8% to
reach $13.8 billion by 2018. The high growth rate during 2005-2010 is
primarily attributed to the launch of biologics such as Enbrel
(etanercept), Remicade(infliximab),
Humira (adalimumab) and Rituxan (rituximab).
Read more ...
Global
Carbon Nanotubes Market - SWCNTS, MWCNTS, Technology, Applications,
Trends & Outlook (2011 - 2016)
Carbon nanotubes are
minuscule allotropes of carbon having sizes to the scale of nanometers.
Their physical, electrical, and thermal properties make them special
material for a number of applications. CNTs have very high tensile
strength, excellent electrical conductivity, and the ability to bear
high working temperatures. May 2011
The Impacts of Nanotechnology on Companies: Policy Insights from
Case Studies
This book from the OECD examines the
potential economic impacts of nanotechnology, how companies are using
nanotechnology for innovation, and what the key challenges in its
commercialisation might be. March 2011
The top 10 orthopedic device companies: financial performance, research
activities, and growth strategies
The report provides detailed profiles of the top 10 orthopedic device
companies and brief profiles of five other major players. It elucidates
trends associated with companies that develop, manufacture, and market
orthopedic devices. Detailed profiles contain descriptions of products,
financial performance, and growth strategies together with SWOT
analyses. March 2011
Top ten medical device technologies
This report identifies the sectors with the industry's most important
developments related to patient care, clinical outcomes, and new product
development. While the scope of the report is limited to the top ten
technologies only, it covers almost the entire medical device market.
February 2011
Nanotechnology market report to 2013
The global nanotechnology market is projected to grow at a CAGR of
around 19% during 2011-2013. The report expects that the global market
for nanotechnology based manufactured goods will be of worth US$ 1.6
Trillion, representing a CAGR of around 50% during 2009-2013. February
2011
Healthcare IT Market Outlook in United Kingdom to 2016
Segments covered include Electronic Medical Records, (EMR), Pharmacy
Information Systems, Laboratory Information Systems, Clinical Decision
Support Systems, Cardiology Information Systems, PACS, Radiology
Information Systems (RIS) and Others. (Pub Aug 2010)
Also market outlooks for the following countries:
(goes to the
ReportBuyer secure server)
Germany
United States
China
Italy
Spain
France
Brazil
India
Personalized Medicine Market. Advances in Human Genomics and Proteomics
to Challenge Traditional Therapeutics
This report provides key data, information and analysis of
the major trends and issues in Personalized Medicine Market. It gives
a comprehensive insight into the role of Human Genomics and Proteomics
to challenge traditional therapeutics and a detailed analysis of market
characterization of personalized medicine market in terms of its market
size, segmentation by key geography types and the major market drivers
and barriers. 3 Dec 2010
Nanobiotechnology
Nanobiotechnology,
an integration of physical sciences, molecular engineering, biology,
chemistry and biotechnology holds considerable promise of advances
in pharmaceuticals and healthcare. The report starts with an
introduction to various techniques and materials that are relevant
to nanobiotechnology. Application in life sciences research,
particularly at the cell level sets the stage for role of
nanobiotechnology in healthcare in subsequent chapters.
more ...
2 Nov 2010
Innovations in Combating Infectious
Diseases
Opportunities in
therapeutics and diagnostics through application of proteomics,
genomics, nanotechnology, and novel sources of lead generation.
This report
makes a detailed and comprehensive analysis of the cutting edge of
research aiming to reveal how bacteria, viruses, fungi, and prions
infect and affect their hosts. It also assesses the new technologies and
techniques that are being used to design and develop the anti-infective
drugs and diagnostic methods of the 21st century. Aug 2010
The European
Hospital Register
This is the most comprehensive, extensive and accurate online database
of European hospitals. It covers over 16,000 hospitals in 23 countries.
Each hospital is indexed by 130 different factors.
Publication Date:
Feb 2010.
Publisher: Walnut Medical
Medical equipment quarterly deals analysis: M&A and investments
trends — Q2 2010
The report provides detailed
information on M&A, Equity/Debt Offerings, Private Equity, Venture
Financing and Partnership transactions registered in the medical
equipment industry in Q2 2010. 17 August 2010
Hormone Replacement Therapy in Menopause — pipeline assessment and
market forecasts to 2017
The global
hormone therapy (HT) market was worth $2.4 billion in 2009, indicating
a Compound Annual Growth Rate (CAGR) of -5.9% between 2001 and 2009.
This decline in the market is mainly attributed to poor patient
compliance as a result of the serious safety concerns associated with
hormones. 1 August 2010
Hip and Knee Implants — global pipeline analysis, opportunity
assessment and market forecasts to 2016
The report
provides market landscape, competitive landscape and market trends
information the hip and knee implants market. The report provides
comprehensive information on the key trends affecting the market, and
key analytical content on the market dynamics. The report also reviews
the competitive landscape and technology offerings. 1 August 2010
Insulin Pumps — Global Pipeline Analysis, Opportunity Assessment
and Market Forecasts to 2016
This report provides market
landscape, competitive landscape and market trends information on
insulin pumps, a key segment in the diabetes care devices market. 29
July 2010
Orthopedic device market outlooks to 2016: country reports for Canada, Germany, France, Italy, Spain, Australia, Netherlands, Belgium, Argentina, Mexico, Republic of Korea, Taiwan, South Africa, Israel, United Kingdom, Japan, India, China, United States. 29 July 2010
In vitro diagnostics market outlooks to 2016: country reports for US, UK, Canada, Italy, Spain, Brazil, Netherlands, Republic of Korea. 29 July 2010
Picture archiving and communication systems (PACS) — global
opportunity assessment, competitive landscape and market forecasts to
2016
The report provides market landscape, competitive
landscape and market trends information the Picture Archiving and
Communication Systems (PACS) market. It provides comprehensive
information on the key trends affecting the market, and key analytical
content on the market dynamics. The report also reviews the competitive
landscape and technology offerings. Key geographies covered include the
US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India,
Australia, and Brazil. July 2010
Allergic Rhinitis — Pipeline Assessment and Market Forecasts to
2017
The report is an essential source of information
and analysis on the global allergic rhinitis market. The report
identifies the key trends shaping and driving the global allergic
rhinitis market. The report also provides insight on the prevalent
competitive landscape and the emerging players expected to significantly
shift the market positioning of the existing market leaders. Most
importantly, the report provides valuable insights on the pipeline
products within the global allergic rhinitis sector. July 2010
Hemophilia — Pipeline Assessment and Market Forecasts to 2017
The report is an essential source of information and analysis on the
global hemophilia market. The report identifies the key trends shaping
and driving the global hemophilia market. The report also provides
insights on the prevalent competitive landscape and the emerging players
expected to significantly alter the market positioning of the current
market leaders. July 2010
Report:
Global orthopedic devices pipeline landscape: analysis of key upcoming
products and technologies
Key data, information and
analysis on the key orthopedic pipeline devices expected to hit the
market in the next seven years. The report provides information on the
market potential, market scope and expected market penetration of these
products. It also identifies and reviews the existing competing
technologies and the likely impact of the launch on the competitive
landscape. May 2010
Practical Guide to Finding Partners in Pharma and Biotech 3rd
edition
The report takes the reader through the
practical steps required to prepare for partnering, prepare supporting
materials, identify and shortlist potential partners and opportunities,
identifying and contacting the right person in the partner company, and
managing of discussions through to deal negotiation.
Molecular
Diagnostics
This report describes and evaluates the
molecular diagnostics technologies that will play an important role in
practice of medicine, public health, pharmaceutical industry, forensics
and biological warfare in the 21st century. This includes several
polymerase chain reaction (PCR)-based technologies, fluorescent in situ
hybridization (FISH), peptide nucleic acids (PNA), electrochemical
detection of DNA, biochips, nanotechnology and proteomic technologies.
April 2010
The Worldwide Market for Cancer Diagnostics. 4th Edition
This report authored by Kalorama Diagnostic Analyst Shara Rosen,
contains detailed market data on the following IVD segments for their
use in cancer diagnostics: Histology/Cytology, Immunoassays, Flow
Cytometry, Rapid Tests, Molecular Assays, Tissue Arrays, Circulating
Tumor Cells, Pharmacodiagnostics. 2010
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics
The report provides comprehensive understanding and unprecedented access
to the merger and acquisition (M&A) agreements entered into by the
worlds leading biopharma companies from 2003 to end 2009.
Deals and alliances — January
2010
Life science companies' deals and alliances research,
intelligence and forecasts — reports for over 200 companies.
The latest biotechnology
industry reports — January 2010
DNA sequencing, nanobiotechnology, proteomics, RNAi, regenerative
medicine etc
Europe Nuclear Imaging Equipment.
Market Analysis and Opportunity Assessment
The report provides market landscape, competitive landscape and
market trends information on market categories: gamma camera, single
photon emission computed tomography, and positron emission tomography.
More information and Buy online ...
Contrast Media: A Market Snapshot
Contrast agents, also known as contrast media, are used during medical
imaging examinations to highlight specific parts of the body and enhance
their contrast. The study looks at the global contrast media market,
both in terms of revenue and geographic segmentation, during 2008-2015.
More information
and Buy online ...
Bristol-Myers Squibb Co.: PharmaVitae Profile
This analysis examines the historical and forecast performance for BMS
in the prescription pharmaceutical sector. The profile encompasses
global company strategy, portfolio and pipeline analysis and assessment
of financial performance, with 1-6 year sales forecasts for key drugs.
Sept 2009
AstraZeneca plc: PharmaVitae Profile
This analysis examines the historical and forecast performance for
AstraZeneca in the Rx pharmaceutical sector. The profile encompasses
global company strategy, portfolio and pipeline analysis and assessment
of financial performance, with 1-6 year sales forecasts for key drugs.
Sept 2009
Abbott Laboratories: PharmaVitae Profile
This analysis examines the historical and forecast performance for
Abbott in the prescription pharmaceutical sector. The profile
encompasses global company strategy, portfolio and pipeline analysis and
assessment of financial performance, with 1-6 year sales forecasts for
key drugs. Sept 2009
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In
Europe
The companies profiled in this report are located across Europe from the
United Kingdom and France to Hungary and Poland. They manufacture the
whole spectrum of imaging equipment including: Analog & Digital X-ray
Systems, Mobile X-ray Units, Mobile C-Arms, Dental X-ray Devices,
Fluoroscopic Imaging Systems, Analog & Digital Mammography Systems,
Mobile Mammography Units, Ultrasound Scanners & Transducers, MRI
Systems, CT Scanners And Nuclear Medicine Imaging Devices.
more ...
Europe Remote Patient Monitoring Market
The report identifies the key trends shaping and driving the dynamism in
the Europe remote patient monitoring market. The report also provides
insight on the prevalent competitive landscape and on the emerging
players which are expected to bring significant shift in the market
standing of the existing leaders. The report also provides valuable
insight on the pipeline products within the Europe remote patient
monitoring market. August 2009
more ...
Medical Equipment Industry Deals Analysis — September 2009
An essential source of data and trend analysis on the mergers and
acquisitions and financings in the medical equipment market. The report
provides detailed information on M&A, Equity/Debt Offerings, Private
Equity, Venture Financing and Partnership transactions registered in the
medical equipment industry in August 2009. The report portrays detailed
comparative data on the number of deals and their value in the last six
months subdivided by deal types, segments, and geographies.
Additionally, the report provides information on top financial advisory
firms in the medical equipment industry. Sept 2009
more ...
Germany Diagnostic Imaging Market Analysis and Forecasts to 2015
GlobalData's report provides market landscape, competitive landscape and
market trends information on six market categories including Computed
Tomography Systems, Mammography Equipment, MRI Systems, Nuclear Imaging
Equipment, Ultrasound Systems and X-Ray Systems. The report provides
comprehensive information on the key trends affecting these categories,
and key analytical insight on the market dynamics. The report also
reviews the competitive landscape in terms of mergers and acquisitions,
pipeline products and technology offerings. Sept 2009
more ...
UK Diagnostic Imaging Market Analysis and Forecasts to 2015
This report by GlobalData provides market landscape,
provides competitive landscape and market trends information on six market
categories including Computed Tomography Systems, Mammography Equipment,
MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-Ray
Systems. The report provides comprehensive information on the key trends
affecting these categories, and key analytical insight on the market
dynamics. The report also reviews the competitive landscape in terms of
mergers and acquisitions, pipeline products and technology offerings.
more ...
In Vitro Diagnostics in a Recession
It is commonly asserted that in vitro diagnostics is a recession-proof
industry. This report tests that assumption: What impact is the downturn
having on in vitro diagnostic companies? What are the best areas of IVD
and the best world markets? How should companies price and market their
products? What are key companies in the market doing at this time?
more ...
Top Ten Global In-Vitro Diagnostics Companies
The global in-vitro diagnostics (IVD) market is forecast to grow at a
rate of 6% to reach $50.0bn in 2012. Roche is the largest player in the
market with a share of 20%. It is followed by Siemens and Abbott, who
both hold 12% of the market. The IVD market is highly consolidated, with
the top ten players holding close to 80% market share. A number of large
in-vivo players have entered the IVD market recently, signalling the
convergence of the two diagnostic fields. Siemens Healthcare is a
prominent example of this trend, following their acquisition of DPC,
Bayer Diagnostics and Dade Behring.
more ...
Top 10 Biotech Companies. Market Outlook, 2008-2023
The global biotech drug market was worth over $75bn in 2007, with
double-figure growth noticeably higher that that of the overall
pharmaceutical market. This report will help you to understand those
developments and their significance. That report provides valuable
commercial information on this exciting industry that no healthcare
company should ignore.
read more ...
Bioinformatics
Markets: Strategies, Business Models and Trends for the Future
This study is arranged to provide an overview of bioinformatics market
segments and offer evidence that these segments are poised for
significant future growth. Each segment is accompanied by analysis and
forecasts by product type and application. March 2009.
read more ...
British
National Formulary
Medicines prescribed in the UK, with special reference to their uses,
cautions, contra-indications, side-effects, doses and relative costs.
read more ...
Personalized Medicine. Scientific & Commercial Aspects
The aim of personalized medicine or individualized treatment is to
match the right drug to the right patient and, in some cases, even to
design the appropriate treatment for a patient according to his/her
genotype. This report describes the latest concepts of development of
personalized medicine based on pharmacogenomics,
pharmacogenetics, pharmacoproteomics, and metabolomics.
Biochip/microarray technologies are also important and bioinformatics is
needed to analyze the immense amount of data generated by various
technologies. more ...
Diabetes Drug
Pipeline. Competitor Analysis
The Competitive Intelligence Report Diabetes Drug Pipeline as of
November 2008 provides a competitor analysis in the development pipeline
of novel antidiabetic treatment modalities for type 1 and 2 diabetes.
The report includes an overview of the major marketed diabetes drugs and
the respective markets sizes and describes the corporate diabetes drug
product portfolios and R&D pipelines of more than 160 companies
worldwide. November 2008
Biopharmaceutical Expression Systems and Genetic Engineering
Technologies. Current and Future Manufacturing Platforms
In currently marketed products there has been little basic change in the
technologies used for commercial-scale manufacture of biopharmaceutical
products. New expression systems and recent improvements available for current
systems have the potential to revolutionize the biopharmaceutical industry! Lower
costs and efficiencies of newer expression systems are driving these
changes. This book provides manufacturers with the information they need
to make the shift to increased productivity. November 2008
Why do drugs fail?
This report analyses recent drug failure events and examines
potential areas of remedy for regulators and companies. Greedy companies
being economical with the truth?
Overzealous regulators pursuing political agendas? Poorly designed or
inconclusive clinical trials? What action can the industry and
regulators take to improve their performance in this critical area?
November 2008
Global Surgical Equipment Investment Opportunities, Analysis and
Forecasts to 2012
This report is an essential source for key information and data
relating to the Global surgical equipment market. The report provides
overview of key trends, drivers and restraints, future outlook, pipeline
products, news, financial deals and competitive landscape and key
developments in the Global surgical equipment devices market. It also
offers global and country level, detailed and comprehensive coverage of
market revenue, volume, distribution and company share information.
October 2008
Global Patient Monitoring Investment Opportunities, Analysis and
Forecasts to 2012
This report is an essential source for key information and data
relating to the Global patient monitoring devices market. The report
provides overview of key trends, drivers and restraints, future outlook,
pipeline products, news, financial deals and competitive landscape and
key developments in the Global patient monitoring devices market. It
also offers global and country level, detailed and comprehensive
coverage of market revenue, volume, distribution and company share
information. October 2008
Western Europe, Healthcare Sector Pulse, April-June 2008
This Health Industry Insights update describes the Western
European healthcare sector environment (payers and providers) in the
second quarter of 2008 and discusses the macroeconomic and
healthcare sector-specific trends. The main section looks at the
major ICT contracts signed over the same period and other
initiatives in place. Includes the NHS-Fujitsu case.
September 2008
Nanobiotechnologies applications, markets and companies
The report starts with an introduction to various techniques and
materials that are relevant to nanobiotechnology. It includes some of
the physical forms of energy such as nanolasers. Some of the
technologies are scaling down such as microfluidics to nanofluidic
biochips and others are constructions from bottom up. Application in
life sciences research, particularly at the cell level sets the stage
for role of nanobiotechnology in healthcare in subsequent chapters.
October 2008.
Read more ...
Nanotechnology. Revolutionizing R&D to Develop Smarter Therapeutics and
Diagnostics
Nanotechnologies have already attracted over $3bn of global government
funding as part of efforts to enhance a range of disciplines including
pharmaceuticals, drug delivery and healthcare monitoring. Advances in
nanomaterials, nanostructures and nanosystems are expected to drive the
value of the global nanotehnology market to over a trillion dollars by
2015, but many companies are remaining cautious, preferring to monitor
developments in academia prior to making substantial investments.
read more ...
Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related
assays or tests used in drug R&D. The study reviews this dynamic market
by looking at drug research and development spending trends, M&As,
alliances, major diseases, applications, tools, technologies, products
and services. This report suggests the future direction of the market
for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or
tests used in the next-generation of drug R&D. This study sizes the
world market and growth rate of biomarkers and assays for drug R&D
spending to 2012. October 2008
Read more ...
RNA interference
markets
Since its discovery, the naturally occurring RNA (ribonucleic acid)
interference effect has been acclaimed as the most exciting technical
breakthrough in biological research in the last decade. Some industry
analysts predict that RNA interference (RNAi) may even surpass PCR as a
top technology. Read more
...
Medical Nanotechnology Markets
Nanotechnology has reached critical mass. Nowhere is this more evident
than in medicine. Rising medical costs, demands for less-invasive
procedures and pressures for immediate feedback of medical conditions,
all point to nanotechnology as offering a new approach in healthcare.
According to US National Science Foundation estimates, by 2015 the
annual global market for nano-related goods and services will top $1
trillion, thus making it one of the fastest-growing industries in
history. Read more
...
Molecular Diagnostics.
Technologies, Markets and Companies
This best-selling report describes and evaluates the molecular
diagnostics technologies that will play an important role in practice of
medicine, public health, pharmaceutical industry, forensics and
biological warfare in the 21st century. Aimed at chief executives and
chief development officers, it is the most comprehensive and up-to-date
one-stop source of information on technical and commercial aspects of
molecular diagnostics. It includes profiles of 250 companies
more ...
Point of Care
Diagnostic Testing. World Markets
The report describes the specific market segment of the in vitro
diagnostics market called point-of-care testing (POCT). It examines
these clinical measurement devices and their reagents and supplies as
utilized in near-patient environments like hospitals, clinics and
doctor's offices. The study defines the dollar volume of sales, both
worldwide and in the US, and analyzes the factors that influence the
size and the growth of the market segments.
more ... September
2008
Top 20
cancer therapy brands
Cancer therapy brand sales totaled over $30 billion in the seven major
markets in 2007, growing by 20.1% since 2006. The high growth of this
market makes it attractive to companies keen to emulate the blockbuster
status achieved by several brands. However, with several impending
patent expiries due, companies will need to work hard to maximize their
return throughout the lifecycle of their brands. September 2008.
Read more ...
Antidiabetics — Switching to new antidiabetics drives market growth
Datamonitor expects the antidiabetics market in the seven major markets is expected to
grow from $18 billion in 2007 to $29 billion in 2017 at a rate of 5%
CAGR. Significant unmet needs remain in diabetes fuelling a large
pipeline. The epidemiological growth of the market, driven by the
obesity epidemic and improved diagnosis rates, is further driving the
market. September 2008.
Read more ...